These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20711432)

  • 1. Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.
    Cui L; Ohuchida K; Mizumoto K; Moriyama T; Onimaru M; Nakata K; Nabae T; Ueki T; Sato N; Tominaga Y; Tanaka M
    PLoS One; 2010 Aug; 5(8):e12121. PubMed ID: 20711432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.
    Hsu CS; Tung CY; Yang CY; Lin CH
    PLoS One; 2013; 8(4):e61133. PubMed ID: 23577199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
    Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
    Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.
    Thomas-Pfaab M; Annereau JP; Munsch C; Guilbaud N; Garrido I; Paul C; Brousset P; Lamant L; Meyer N
    J Dermatol Sci; 2013 Feb; 69(2):105-13. PubMed ID: 23219141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
    Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
    Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
    Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
    Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
    Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer.
    Puglisi MA; Sgambato A; Saulnier N; Rafanelli F; Barba M; Boninsegna A; Piscaglia AC; Lauritano C; Novi ML; Barbaro F; Rinninella E; Campanale C; Giuliante F; Nuzzo G; Alfieri S; Doglietto GB; Cittadini A; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():55-62. PubMed ID: 19530513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD133 correlates with differentiation of human colon cancer cells.
    Feng HL; Liu YQ; Yang LJ; Bian XC; Yang ZL; Gu B; Zhang H; Wang CJ; Su XL; Zhao XM
    Cancer Biol Ther; 2010 Feb; 9(3):216-23. PubMed ID: 20023382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
    Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
    J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.
    Gallmeier E; Hermann PC; Mueller MT; Machado JG; Ziesch A; De Toni EN; Palagyi A; Eisen C; Ellwart JW; Rivera J; Rubio-Viqueira B; Hidalgo M; Bunz F; Göke B; Heeschen C
    Stem Cells; 2011 Mar; 29(3):418-29. PubMed ID: 21308861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells.
    Deng YH; Pu XX; Huang MJ; Xiao J; Zhou JM; Lin TY; Lin EH
    Chin J Cancer; 2010 Sep; 29(9):810-5. PubMed ID: 20800023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
    Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
    Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.